Latest Earli News & Updates

See the latest news and media coverage for Earli. We track all announcements, press releases, and industry mentions in real time, all in one place.

Earli

Developer of tumor-selective genetic therapies and diagnostics

earli.com

Headquarters: Redwood City, United States
Founded year: 2018
Company type: Private company
Number of employees: 30–50

Last updated Today

Latest news about Earli

In short: Earli secured $104 million in total funding to advance its synthetic biopsy platform for early cancer detection and treatment.

Company announcements

January 14 Earli

Earli CEO urges Trump to prioritize biotech innovations

He highlights U.S. funding challenges, China's rise, and proposes a national biotech fund and regulatory reforms. Biotech faces structural risks threatening leadership.

16 August 2025 Earli

Earli announces $44m funding to reprogram cancer cells

The total funding raised by Earli is now $104m. Investors include a16z Bio + Health, Khosla Ventures, and new prominent backers. The company aims to start clinical trials soon.

21 January 2025 Earli

Earli presents new cancer treatment at DLD Munich

The post discusses Earli's innovative approach to cancer treatment showcased at the DLD Munich event on January 21, 2025.

6 December 2024 Earli

Earli celebrates the holiday season

Earli combines cutting-edge biotechnology with traditional holiday spirit in their seasonal greeting.

Media coverage

April 23 Axios

Exclusive: Cancer biotech Earli seeks $60M Series B

Earli, a Bay Area biotech developing novel cancer drugs, is seeking to raise a $60 million Series B round, CEO Cyriac Roeding tells Axios Pro...

12 June 2025 The Scientist

Earli Profile | The Scientist

Earli is a Stanford spinout developing a new approach to cancer treatment and tackling the “holy grail” in oncology of destroying cancer cells while safeguarding...

20 December 2024 Entrepreneur

The Heartbreaking Loss of a Child to Cancer Brought These 3 Founders Together. Now Their Startup Has Raised $60 Million to Fight and Treat the Disease With Cutting-Edge Tech. | Entrepreneur

What happens when a Silicon Valley entrepreneur, a synthetic biology expert, and a world-renowned cancer researcher team up? They create Earli—a startup rewriting the rules...

19 September 2024 TechTarget

Using synthetic biomarkers for early cancer detection | TechTarget

Accenture invests in Earli Inc., a biotechnology company that is using synthetic targeting platforms for early cancer detection.

Never miss news about Earli

Track Earli and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.